关于我们

Enterprise Value Enhancement – Chinese M&A Investment in Germany

Is China taking over Germany? China was the biggest source of foreign direct investment (FDI) in Germany in 2015 and 2016 and the number and size of deals are climbing steadily.

Omar Ahmad

Omar Ahmad is a Senior Partner and Managing Partner Global Healthcare & Life Sciences at Simon-Kucher.

我们的领导者和专家

Dominic Seitz

Dominic is a Partner in Simon-Kucher’s Life Sciences division in Frankfurt. He helps develop and drive strategic launch and lifecycle product and portfolio strategies for global pharmaceutical and biotechnology companies

Wenbo Li (李文博)

Wenbo is a partner in Simon-Kucher’s Asia-Pacific division and is based in the Shanghai office. He leads the Technology, Media & Telecommunications (TMT) sector and B2B consulting projects in the Greater China area.

Dave Clement

Dave is a Partner and Head of Simon-Kucher’s New York office, where he supports top-line growth strategy design and implementation for clients in a variety of industries. Dave’s areas of expertise include customer segmentation, price setting and implementation, product and service design, and rewards and loyalty programs.

Svante Zetterqvist

Svante is a Partner Simon-Kucher.

Jan Haemer

Jan Haemer is a Partner in Simon-Kucher's global Chemicals & Construction practice in Frankfurt. His focus is product portfolio management, marketing & pricing strategy, as well as price management frameworks and their implementation. He has worked for various chemicals, building and base materials producers in contested market environments as well as more for specialized products.

Nathan Swilling

Dr. Nathan Swilling is a Senior Partner and Co-Head of the global Pharma & Biotech practice within Simon-Kucher's Life Sciences activities in Boston. Since joining the company in 2004, he has specialized in strategic marketing, access planning, pricing, and reimbursement of pharmaceuticals and biotech products.